Network geometry of evidence from randomised controlled trials addressing donor selection and source of haematopoietic progenitor cells used in allogeneic transplantation: a systematic scoping review

ConclusionMore RCTs that enrol greater numbers of similar patients are needed to leverage the current evidence network concerning donor choice and source of cells used in allogeneic HCT.

Source: Transfusion Medicine - December 1, 2017 Category: Hematology Authors: M. Monaghan, M. Rizk, S. Pilon, A. Iyengar, R. Shorr, J. Tay, D. Maze, C. Bredeson, B. Hutton, D. S. Allan Tags: ORIGINAL ARTICLE Source Type: research